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Patient: 71 years, male
Clinical History:
A 71-year-old man with significant history of alcoholic liver cirrhosis with portal hypertension presenting at the 
emergency department with profuse haematemesis. Transjugular intrahepatic portosystemic shunt (TIPS) was 
performed. In the following 3 days, the patient deteriorated neurologically with reduced level of consciousness and 
seizures. Lab tests (hyperammonaemia 152µmol/L (5-55 µmol/L)) and MRI were performed to investigate the 
altered mental state. MRI was obtained 6 days after the first epileptic event.
Imaging Findings:
Figure 1: Axial T2-FLAIR image of the brain shows demarcated symmetrical swelling and oedema of the insular 
cortex, cingulate gyrus and medial frontal cortex, as well as signal abnormalities in both caudate nuclei and thalami. 
(Fig. 1)
Figure 2: Axial T2-FLAIR image of the brain on a lower level shows demarcated symmetrical swelling and oedema 
of the insular temporal cortex and hippocampi and sparing of the occipital cortex. (Fig. 2)
Figure 3: Diffusion-weighted image (a) and ADC map (b) shows clear signal hyperintensity in the swollen cortical 
zones. The ADC map shows concordant hypointensities, confirming the restricted diffusion. (Fig. 3a, b)
Figure 4: Follow-up T2-FLAIR image of the brain after 15 days at the same level as Fig. 1, comparison shows 
decreased oedematous aspect of the affected cortex.
Figure 5: Follow-up DWI (a) and ADC (b) of the brain after 15 days at the same level as Fig. 3, comparison shows 
decreased oedematous aspect of the affected cortex.
Discussion:
1. Background
Acute hyperammonaemic encephalopathy (AHAE) or portal-systemic encephalopathy represents a potentially 
reversible clinical syndrome during acute liver disease with impairment of neuropsychiatric function. Due to 
portosystemic shunting, there is no metabolisation of ammonia in the liver. Although the exact mechanism of 
neurotoxicity is not known, the uptake of ammonia by the brain has been shown to be toxic to astrocytes. It is not 
known why the insular and cingulate cortices seem particularly susceptible to the toxic effects of hyperammonaemia. 
[1] This case shows a possible side effect of TIPS placement. Once the TIPS is placed, toxin-rich blood bypasses 
the liver via the portosystemic shunt. This will cause an acute rise of many waste product blood levels like ammonia 
which will no longer be broken down into urea. Together with the excessive nitrogen-containing intestinal load 
following the recent GI bleeding, it results in an even higher ammonia blood level.
 
2. Clinical Perspective
Symptoms of AHAE range from changes in behaviour, mild confusion, slurred speech and disordered sleep to coma 
and unresponsiveness to pain. Because of the non-specific nature of these symptoms, additional lab tests and 
imaging are required to narrow down the differential diagnosis. High blood ammonia levels (above 55 µmol/L) and 
specific patterns of imaging findings should alert the clinician. [1] Subsequently, it is of great importance that 
radiologists recognise this pattern and report the likely association with hyperammonaemia.
 
3. Imaging Perspective
Key findings in AHAE are bilateral symmetrical T2/FLAIR hyperintense signal in the cortex of the insula and 
cingulate gyrus, and sparing of the perirolandic and occipital cortex. There can be a varying extension and degree of 
symmetry in the affected frontal, temporal and parietal cortices. Signal abnormalities in the thalami and globi pallidi 
are also a frequent finding, indicative of a pre-existing chronic disease. [2-4]
Proton-MR-spectroscopy can be performed when available and will show an increase in the glutamate/glutamine 
resonance and a decrease in the myo-inositol and choline resonances. [5]
 
4. Outcome
Findings show that the cortical changes appear to be early and reversible findings, if aggressive treatment is 
instituted. Probably the plasma ammonium levels may reflect the extent of the injury. Commonly used treatments for 
hepatic encephalopathy aim to reduce ammonia production and absorption. This is accomplished by correcting 
hypokalaemia, giving synthetic disaccharides (such as lactulose) and/or antibiotics, and favouring colonisation with 
non-urease-producing bacteria. Or in this case, if medication doesn’t work, reducing the TIPS. Patients with hepatic 
encephalopathy may have persistent and cumulative neurologic deficits despite an apparent normalisation of mental 
status after treatment (deficits in working memory, response inhibition, and learning when assessed by psychometric 
testing). [6]
Follow-up MRI was performed 15 days after the first MRI-scan and showed marked decrease of cerebral oedema. 
In an effort to treat the encephalopathy even more, the TIPS was occluded endovascularly. Unfortunately the patient 
in this case died due to recurrent GI bleeding.
 
5. Take Home Message / Teaching Points
Symmetrical cortical signal abnormalities in the insular cortex and cingulate gyrus with sparing of the perirolandic 
and occipital cortices are key findings in MRI imaging of AHAE. The diagnosis should be suggested particularly if 
there is a recent history of TIPS placement.
Written informed patient consent for publication has been obtained.
Differential Diagnosis List:  Acute hyperammonaemic encephalopathy after TIPS, Hypoxic-ischaemic brain injury, 
Acute hyperammonaemic encephalopathy, Uraemic encephalopathy, Valproate-induced hyperammonaemia, Adult-
onset citrullinaemia, Reye syndrome, Creutzfeld-Jakob disease 
Final Diagnosis:  Acute hyperammonaemic encephalopathy after TIPS 
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Figure 1
a
Description: Axial T2-FLAIR image of the brain shows demarcated symmetrical swelling and oedema 
of the insular cortex, cingulate gyrus and medial frontal cortex, as well as signal abnormalities in both 




Description: Axial T2-FLAIR image of the brain on a lower level shows demarcated symmetrical 
swelling and oedema of the insular temporal cortex and hippocampi and sparing of the occipital cortex. 
(Fig. 2) Origin: Radiology Department, University Hospital of Ghent (UZGent)
Figure 3
a
Description: Diffusion-weighted image (a) and ADC map (b) shows clear signal hyperintensity in the 
swollen cortical zones. The ADC map shows concordant hypointensities, confirming the restricted 
diffusion. (Fig. 3a, b) Origin: Radiology Department, University Hospital of Ghent (UZGent)
b
Description: Diffusion-weighted image (a) and ADC map (b) shows clear signal hyperintensity in the 
swollen cortical zones. The ADC map shows concordant hypointensities, confirming the restricted 
diffusion. (Fig. 3a, b) Origin: Radiology Department, University Hospital of Ghent (UZGent)
Figure 4
a
Description: Follow-up T2-FLAIR image of the brain after 15 days at the same level as Fig. 1, 
comparison shows decreased oedematous aspect of the affected cortex.Origin: Radiology 
Department, University Hospital of Ghent (UZGent)
Figure 5
a
Description: Follow-up DWI (a) and ADC (b) of the brain after 15 days at the same level as Fig. 3, 
comparison shows decreased oedematous aspect of the affected cortex.Origin: Radiology 
Department, University Hospital of Ghent (UZGent)
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Description: Follow-up DWI (a) and ADC (b) of the brain after 15 days at the same level as Fig. 3, 
comparison shows decreased oedematous aspect of the affected cortex.Origin: Radiology 
Department, University Hospital of Ghent (UZGent)
